Pharmaceutical companies are already cashing in on their other health benefits.

Financial Times

London

Greater London

England

United Kingdom

Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease

Ad Fontes Media

All Sides

Media Bias/Fact Check

Nikkei Inc.

Drugs are “anti-hedonic” and can give patients a break from their dependence, Executive Director Dave Ricks said.

Los fármacos son “antihedónicos” y pueden ofrecer a los pacientes un respiro de su dependencia, dijo el director ejecutivo Dave Ricks

Lilly probará sus fármacos contra la obesidad para tratar las adicciones el próximo año

larepublica.co

Bogotá

Bogota

Colombia

Lilly will test her anti-obesity drugs to treat addictions next year

14:57 ‘I’m a data man. And the numbers are clear. Europe is losing ground to the United States and China.’ Ilya Yuffa, responsible for the international strategy of the American bigphar...

14:57 ‘I’m a data man. En de cijfers zijn duidelijk. Europa verliest terrein tegenover de Verenigde Staten en China.’ Ilya Yuffa, verantwoordelijk voor de internationale strategie van de Amerikaanse bigphar...

Topper van Eli Lilly, 's werelds waardevolste bigpharmabedrijf: ‘Europa verliest terrein’

De Tijd

Belgium

Eli Lilly's Top Executive, World's Most Valuable Big Pharma Company: 'Europe Is Losing Ground'

Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster drug as a treatment for alcohol and drug addiction starting next year.Read more...

Quartz

United States

What can't weight-loss meds do? Eli Lilly is going to test Zepbound as a treatment for addiction

Emerging research suggests that GLP-1 drugs not only reduce food cravings but may also suppress desires for other substances.

STAT

The Boston Globe

Boston

Suffolk County

Massachusetts

Eli Lilly to test obesity medications as treatments for alcohol and drug addiction, CEO says

Although research to date has focused on obesity, Ozempic, Wegovy and Moungaro could be used for addiction, heart disease and Alzheimer's. Read

Aunque hasta la fecha las investigaciones se han centrado en la obesidad, Ozempic, Wegovy y Mounjaro podrían utilizarse para la adicción, las enfermedades cardíacas y el Alzheimer. Leer

¿Qué otras enfermedades podrían tratarse con medicamentos para bajar de peso?

Expansión

What other diseases could be treated with weight loss medicines?

Adam Steensberg, the chief executive of Danish biotech Zealand Pharma, which is developing an alternative weight... The post Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease appeared first on MASSIVE News.

MASSIVE.NEWS

One of Dr Mo Sarhan’s patients was experiencing intense cravings for opioids and alcohol when the Florida-based doctor offered him a striking solution: the Eli Lilly weight-loss drug Mounjaro. “Within days, all of his cravings were gone and he was much more effective in his engagement and treatment. He’s done great since,” Sarhan says. Sarhan […]

Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics